OBJECTIVE: The aim of this study was to evaluate the concentrations of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and the degree of homeostasis model assessment-insulin resistance (HOMA-IR) in patients with morbid obesity exposed to a three-week low-calorie diet and balneotherapy. METHODS: The study included 33 patients (25 females and 8 males; mean age 46 years) with body mass index (BMI) values of >40 kg/m(2). Evaluations of CRP, IL-6, TNF-α, lipid profile, HOMA-IR, and fasting glucose were carried out before (baseline data) and three weeks after the treatment. The control group consisted of 20 healthy volunteers (15 females and 5 males) with a mean age of 39 years and BMI values of ≤24.9 kg/m(2). RESULTS: In the blood of patients with morbid obesity we found significantly elevated levels of CRP, TNF-α, triglycerides, HOMA-IR and fasting glucose, but a decreased level of high density lipoprotein (HDL)-cholesterol, compared with the healthy individuals. The treatment resulted in about a 9.4% reduction in body weight from 122.5 to 111.0 kg and a significant decrease in the concentration of CRP, but no change in TNF-α or IL-6. HOMA-IR was significantly reduced. CONCLUSIONS: The decrease in CRP level without changes in TNF-α or IL-6 concentrations after the low-calorie diet and balneological treatment, suggests that an essential amount of adipose tissue must be removed before proper adipocyte function is restored. The decrease in HOMA-IR indicates an improvement in insulin sensitivity, which is beneficial in obese patients.
OBJECTIVE: The aim of this study was to evaluate the concentrations of C-reactive protein (CRP), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and the degree of homeostasis model assessment-insulin resistance (HOMA-IR) in patients with morbid obesity exposed to a three-week low-calorie diet and balneotherapy. METHODS: The study included 33 patients (25 females and 8 males; mean age 46 years) with body mass index (BMI) values of >40 kg/m(2). Evaluations of CRP, IL-6, TNF-α, lipid profile, HOMA-IR, and fasting glucose were carried out before (baseline data) and three weeks after the treatment. The control group consisted of 20 healthy volunteers (15 females and 5 males) with a mean age of 39 years and BMI values of ≤24.9 kg/m(2). RESULTS: In the blood of patients with morbid obesity we found significantly elevated levels of CRP, TNF-α, triglycerides, HOMA-IR and fasting glucose, but a decreased level of high density lipoprotein (HDL)-cholesterol, compared with the healthy individuals. The treatment resulted in about a 9.4% reduction in body weight from 122.5 to 111.0 kg and a significant decrease in the concentration of CRP, but no change in TNF-α or IL-6. HOMA-IR was significantly reduced. CONCLUSIONS: The decrease in CRP level without changes in TNF-α or IL-6 concentrations after the low-calorie diet and balneological treatment, suggests that an essential amount of adipose tissue must be removed before proper adipocyte function is restored. The decrease in HOMA-IR indicates an improvement in insulin sensitivity, which is beneficial in obesepatients.
Entities:
Keywords:
C-reactive protein (CRP); Homeostasis model assessment-insulin resistance (HOMA-IR); Interleukin-6 (IL-6); Morbid obesity; Pro-inflammatory cytokines; Tumor necrosis factor-α (TNF-α)
Authors: Luis Alberto Vázquez; Fernando Pazos; José Ramón Berrazueta; Carlos Fernández-Escalante; María Teresa García-Unzueta; Julio Freijanes; José Antonio Amado Journal: J Clin Endocrinol Metab Date: 2004-10-26 Impact factor: 5.958
Authors: Antonios M Xydakis; Christopher C Case; Peter H Jones; Ron C Hoogeveen; Mine-Yine Liu; E O'Brian Smith; Kathleen W Nelson; Christie M Ballantyne Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Thierry Hanh; Patrick Serog; Jérôme Fauconnier; Pierre Batailler; Florence Mercier; Christian F Roques; Patrick Blin Journal: Evid Based Complement Alternat Med Date: 2012-12-24 Impact factor: 2.629
Authors: Fabian Corlier; George Hafzalla; Joshua Faskowitz; Lewis H Kuller; James T Becker; Oscar L Lopez; Paul M Thompson; Meredith N Braskie Journal: Neuroimage Date: 2018-01-28 Impact factor: 6.556
Authors: Kelsey Gabel; Cynthia M Kroeger; John F Trepanowski; Kristin K Hoddy; Sofia Cienfuegos; Faiza Kalam; Krista A Varady Journal: Obesity (Silver Spring) Date: 2019-07-22 Impact factor: 5.002
Authors: Dorota Artemniak-Wojtowicz; Anna M Kucharska; Anna Stelmaszczyk-Emmel; Anna Majcher; Beata Pyrżak Journal: Front Endocrinol (Lausanne) Date: 2022-07-06 Impact factor: 6.055
Authors: Wilson R Freitas; Luis Vicente Franco Oliveira; Eduardo A Perez; Elias J Ilias; Carina P Lottenberg; Anderson S Silva; Jessica J Urbano; Manoel C Oliveira; Rodolfo P Vieira; Marcelo Ribeiro-Alves; Vera L S Alves; Paulo Kassab; Fabio R Thuler; Carlos A Malheiros Journal: Obes Surg Date: 2018-07 Impact factor: 4.129